Antibody drug conjugates (ADC) that bind to FLT3 proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10751422
APP PUB NO 20180037657A1
SERIAL NO

15556587

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antibody drug conjugates (ADC's) that bind to FLT3 protein and variants thereof are described herein. FLT3 exhibits a distinct and limited expression pattern in normal adult tissue(s), and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AGENSYS INC2375 WATERVIEW DRIVE NORTHBROOK IL 60062

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Avina, Hector Los Angeles, US 2 10
Capo, Linnette Sherman Oaks, US 2 10
Liu, Gao Culver City, US 69 408
Lowe, Christine Northridge, US 2 10
Malik, Faisal Hayat Cerritos, US 5 16
Moon, Sung Ju Santa Monica, US 5 16
Rudra-Ganguly, Nandini Santa Monica, US 2 10
Snyder, Josh Santa Monica, US 12 29
Virata, Cyrus Mission Hills, US 2 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 25, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 25, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00